You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 30, 2025

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
Published on: August 31, 2022
Kelly C Harper1, Maxime Ronot1, Michael L Wells1
1From the Department of Radiology, Division of Abdominal Imaging, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905 (K.C.H., M.L.W., C.L.W., J.F., S.K.V.); Department of Medical Imaging, University of Ottawa, Ottawa, Ontario, Canada (K.C.H.); Department of Medical Imaging, Beaujon University Hospital, Clichy, France (M.R.); HT Medica, Madrid, Spain (A.L.); Department of Radiology, University of Vienna, Vienna, Austria (A.B.S.); Department of Radiology, Sun Yat Sen University, Guangzhou, China (J.W.); and Department of Radiology, Division of Abdominal Imaging, Mayo Clinic, Scottsdale, Ariz (A.C.S.).
Hepatobiliary (HB) MRI contrast agents offer insights into liver function and biliary anatomy. Understanding HB phase hypointensity is crucial for diagnosing liver diseases and assessing tumor aggressiveness.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: